Clinical Trials Directory

Trials / Terminated

TerminatedNCT01011647

Prevalence of Sleep Disordered Breathing

Status
Terminated
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
GE Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A novel technique in identifying unspecified sleep apnea has been developed. This technique uses signals typical acquired from a bedside monitor that is found in critical care environments. Those signals are then processed by a sleep analysis algorithm to provide an Apnoea Hypopnea Index (AHI) score. This study is intended to determine whether the prevalence of sleep disordered breathing identification among patients in a Coronary Care Unit (CCU) using this novel approach is significantly different than using routine techniques.

Detailed description

This study will focus on inpatients diagnosed with coronary conditions. Specific eligibility criteria will include: * Unstable angina * Acute myocardial infarction * Congestive heart failure Subjects enrolled in the study will be scored for sleep apnea using a novel approach designed by the sponsor. That score will not be used in the course of treatment. A follow-up call will determine whether the subject was identified for sleep disordered breathing during the hospital stay. A comparison will be done on the number of those identified with and without the use of the sleep scoring device.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2009-11-11
Last updated
2012-01-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01011647. Inclusion in this directory is not an endorsement.